ReviewMarine drugs2017
Structural Insights into the Cytotoxic Mechanism of Vibrio parahaemolyticus PirA
Review in Marine drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 71 citations in OpenAlex.
- In-depth characterization of virulence traits, pathogenicity, antibiogram, and antibiotic resistance genes of MDR Vibrio parahaemolyticus retrieved from shrimp.Scientific reports · 2025Article
- Prevalence, bacterial load, and genomic characterization ofFrontiers in microbiology · 2025Article
- A bacterial binary toxin system that kills both insects and aquatic crustaceans: Photorhabdus insect-related toxins A and B.PLoS pathogens · 2023Review
- Exploring the Effect of Functional Diets Containing Phytobiotic Compounds in Whiteleg Shrimp Health: Resistance to Acute Hepatopancreatic Necrotic Disease Caused byAnimals : an open access journal from MDPI · 2023Article
- Novel sandwich immunoassay detects a shrimp AHPND-causing binary PirABFrontiers in cellular and infection microbiology · 2023Article
- Review
- Expression of the AHPND Toxins PirAInternational journal of molecular sciences · 2022Article
- Characterization of the Novel Phage vB_VpaP_FE11 and Its Potential Role in ControllingViruses · 2022Article
- Identification and Expression Analysis of an Interacting Protein (LvFABP) that MediatesFrontiers in immunology · 2022Article
- The PirB toxin protein fromVirulence · 2021Article
- Targeting PirAAntibiotics (Basel, Switzerland) · 2021Article
- Review
- Generation and evaluation of polyclonal antibodies specific for ToxA fromMolecular biology research communications · 2021Article
- Passive Immunization with Recombinant Antibody VLRB-PirAVaccines · 2021Article
- Differentially Expressed Genes in Hepatopancreas of Acute Hepatopancreatic Necrosis Disease Tolerant and Susceptible Shrimp (Frontiers in immunology · 2021Article
- Do acute hepatopancreatic necrosis disease-causing PirABEmerging microbes & infections · 2020Article
- Antibacterial Activity ofApplied and environmental microbiology · 2020Article
- A Review of the Functional Annotations of Important Genes in the AHPND-Causing pVA1 Plasmid.Microorganisms · 2020Review
- Identification of Arylphorin interacting with the insecticidal protein PirAB from Xenorhabdus nematophila by yeast two-hybrid system.World journal of microbiology & biotechnology · 2020Article
- The B Subunit of PirABPathogens (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In aquaculture, shrimp farming is a popular field. The benefits of shrimp farming include a relatively short grow-out time, high sale price, and good cost recovery. However, outbreaks of serious diseases inflict serious losses, and acute hepatopancreatic necrosis disease (AHPND) is an emerging challenge to this industry. In South American white shrimp (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.